These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38061408)

  • 1. Predicting the next pandemic: VACCELERATE ranking of the WorldHealth Organization's Blueprint forAction toPreventEpidemics.
    Salmanton-García J; Wipfler P; Leckler J; Nauclér P; Mallon PW; Bruijning-Verhagen PCJL; Schmitt HJ; Bethe U; Olesen OF; Stewart FA; Albus K; Cornely OA;
    Travel Med Infect Dis; 2024; 57():102676. PubMed ID: 38061408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.
    Salmanton-García J; Wipfler P; Valle-Simón P; Merakou C; Kopsidas I; Bethe U; Steinbach A; Spivak O; Součková L; Mendonça MA; Koniordou M; Hellemans M; Frías-Iniesta J; Davis RJ; Barta I; Azzini AM; Askling HH; Argyropoulos CD; Álvarez-Barco E; Akova M; Bonten MMJ; Cohen-Kandli M; Cox RJ; Flisiak R; Husa P; Jancoriene L; Koscalova A; Launay O; Lundgren J; Mallon P; Marques L; Nauclér P; Ochando J; Pana ZD; Tacconelli E; Tóth K; Trelle S; van Damme P; Zaoutis TE; Zeitlinger M; Albus K; Stewart FA; Hofstraat SHI; Bruijning-Verhagen P; Cornely OA;
    Vaccine; 2023 Jun; 41(26):3915-3922. PubMed ID: 37210309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global research trends of World Health Organization's top eight emerging pathogens.
    Sweileh WM
    Global Health; 2017 Feb; 13(1):9. PubMed ID: 28179007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VACCELERATE Volunteer Registry: A European study participant database to facilitate clinical trial enrolment.
    Salmanton-García J; Stewart FA; Heringer S; Koniordou M; Álvarez-Barco E; Argyropoulos CD; Themistocleous SC; Valle-Simón P; Spivak O; Součková L; Merakou C; Amélia Mendonça M; Joanna Davis R; Maria Azzini A; Askling HH; Vene S; Van Damme P; Steinbach A; Shiamakkides G; Seidel D; Olesen OF; Noula E; Macken A; Luís C; Leckler J; Launay O; Isitt C; Hellemans M; Frías-Iniesta J; Di Marzo R; Carcas AJ; Boustras G; Borobia AM; Barta I; Albus K; Akova M; Ochando J; Cohen-Kandli M; Jane Cox R; Husa P; Jancoriene L; Mallon P; Marques L; Mellinghoff SC; Nauclér P; Tacconelli E; Tóth K; Zaoutis TE; Zeitlinger M; Cornely OA; Pana ZD;
    Vaccine; 2022 Jul; 40(31):4090-4097. PubMed ID: 35659449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing patterns of infectious diseases in children during the COVID-19 pandemic.
    Yang MC; Su YT; Chen PH; Tsai CC; Lin TI; Wu JR
    Front Cell Infect Microbiol; 2023; 13():1200617. PubMed ID: 37457965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Del Mar CB; Dooley L; Ferroni E; Al-Ansary LA; Bawazeer GA; van Driel ML; Jones MA; Thorning S; Beller EM; Clark J; Hoffmann TC; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD006207. PubMed ID: 33215698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases.
    Jonkmans N; D'Acremont V; Flahault A
    BMJ Glob Health; 2021 Sep; 6(9):. PubMed ID: 34531189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nipah@20: Lessons Learned from Another Virus with Pandemic Potential.
    Gómez Román R; Wang LF; Lee B; Halpin K; de Wit E; Broder CC; Rahman M; Kristiansen P; Saville M
    mSphere; 2020 Jul; 5(4):. PubMed ID: 32641430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
    Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
    Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fogarty International Center collaborative networks in infectious disease modeling: Lessons learnt in research and capacity building.
    Nelson MI; Lloyd-Smith JO; Simonsen L; Rambaut A; Holmes EC; Chowell G; Miller MA; Spiro DJ; Grenfell B; Viboud C
    Epidemics; 2019 Mar; 26():116-127. PubMed ID: 30446431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
    National Immunization Advisory Committee Technical Working Group
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic.
    Marcenac P; McCarron M; Davis W; Igboh LS; Mott JA; Lafond KE; Zhou W; Sorrells M; Charles MD; Gould P; Arriola CS; Veguilla V; Guthrie E; Dugan VG; Kondor R; Gogstad E; Uyeki TM; Olsen SJ; Emukule GO; Saha S; Greene C; Bresee JS; Barnes J; Wentworth DE; Fry AM; Jernigan DB; Azziz-Baumgartner E
    Emerg Infect Dis; 2022 Dec; 28(13):S26-S33. PubMed ID: 36502434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
    Voss G; Jacquet JM; Tornieporth N; Kampmann B; Karron R; Meulen AS; Chen R; Gruber M; Lurie N; Weller C; Cramer JP; Saville M; Darko M
    Vaccine; 2021 Dec; 39(51):7357-7362. PubMed ID: 34799142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Review on Emerging Infectious Diseases Prioritized Under the 2018 WHO Research and Development Blueprint: Lessons from the Indian Context.
    Kojom LP; Singh V
    Vector Borne Zoonotic Dis; 2021 Mar; 21(3):149-159. PubMed ID: 33316200
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics.
    Petersen E; Koopmans M; Go U; Hamer DH; Petrosillo N; Castelli F; Storgaard M; Al Khalili S; Simonsen L
    Lancet Infect Dis; 2020 Sep; 20(9):e238-e244. PubMed ID: 32628905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens.
    Fathi A; Dahlke C; Addo MM
    Hum Vaccin Immunother; 2019; 15(10):2269-2285. PubMed ID: 31368826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of European Patient Advocacy Groups on Volunteer Registries and Vaccine Trials: VACCELERATE Survey Study.
    Themistocleous S; Argyropoulos CD; Vogazianos P; Shiamakkides G; Noula E; Nearchou A; Yiallouris A; Filippou C; Stewart FA; Koniordou M; Kopsidas I; Askling HH; Vene S; Gagneux-Brunon A; Prellezo JB; Álvarez-Barco E; Salmanton-García J; Leckler J; Macken AJ; Davis RJ; Azzini AM; Armeftis C; Hellemans M; Di Marzo R; Luis C; Olesen OF; Valdenmaiier O; Jakobsen SF; Nauclér P; Launay O; Mallon P; Ochando J; van Damme P; Tacconelli E; Zaoutis T; Cornely OA; Pana ZD
    JMIR Public Health Surveill; 2024 Apr; 10():e47241. PubMed ID: 38573762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.